DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$6.82 USD
+0.06 (0.89%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $6.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DMAC 6.82 +0.06(0.89%)
Will DMAC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DMAC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DMAC
DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?
After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright
DMAC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?
Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect?
Other News for DMAC
Day Moving AverageC forms MACD Bearish Signal Line Cross on September 19
The technical outlook for Day Moving AverageC is unchanged after it falls 1.43% on September 17
Day Moving AverageC forms 1,2,3 Pullback Bullish on September 16
Calm After Storm appears for Day Moving AverageC after 1.13% move
Is Day Moving AverageC building bullish momentum? Upper Bollinger Band Walk shows up after slipping 2.61%